Boston Trust Walden’s Ormat Technologies ORA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,332
Closed -$740K 401
2021
Q4
$740K Sell
9,332
-260
-3% -$19.6K 0.01% 304
2021
Q3
$639K Buy
9,592
+229
+2% +$15.8K 0.01% 308
2021
Q2
$651K Buy
9,363
+1,710
+22% +$122K 0.01% 311
2021
Q1
$601K Buy
7,653
+2,876
+60% +$285K 0.01% 312
2020
Q4
$431K Buy
4,777
+700
+17% +$53K ﹤0.01% 327
2020
Q3
$241K Buy
4,077
+680
+20% +$41K ﹤0.01% 353
2020
Q2
$216K Hold
3,397
﹤0.01% 357
2020
Q1
$230K Buy
3,397
+600
+21% +$45.3K ﹤0.01% 336
2019
Q4
$208K Buy
+2,797
New +$212K ﹤0.01% 377

Other funds holding ORA

Boston Trust Walden's ORA Position: Q1 2022 in Review

Boston Trust Walden sold out of Ormat Technologies (ORA) in Q1 2022, closing a stake of 9,332 shares — an estimated $740K sold.

Boston Trust Walden first reported a position in ORA in Q4 2019 and held it in 9 quarters. The position peaked at $740K in Q4 2021. 232 funds tracked by Wall St. Rank hold ORA as of Q1 2022.

  • Boston Trust Walden reported no remaining Ormat Technologies position as of Q1 2022 after selling out during the quarter.
  • Boston Trust Walden sold 9,332 Ormat Technologies shares in Q1 2022, an estimated $740K.
  • Boston Trust Walden first reported a position in Ormat Technologies in Q4 2019 and held it in 9 quarters.
  • Boston Trust Walden's Ormat Technologies position peaked at $740K in Q4 2021.
  • 232 funds tracked by Wall St. Rank held Ormat Technologies as of Q1 2022.

Based on Boston Trust Walden's 13F filing for Q1 2022, filed 20 Apr 2022.